BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37248786)

  • 1. Allergen-specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient.
    Kwon IJ; Park JW; Kim SM; Lee KH; Park CO
    J Dermatol; 2023 Oct; 50(10):1353-1356. PubMed ID: 37248786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergen desensitization reduces the severity of relapsed alopecia areata in dust-mite allergic patients.
    Zeng Z; Li S; Ye Y; Ling Y; Gong Y; Zi X; Yang J; McElwee KJ; Zhang X
    Exp Dermatol; 2023 Jul; 32(7):1108-1119. PubMed ID: 37114716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effectiveness of Allergen Immunotherapy in Adult Patients with Atopic Dermatitis Allergic to House Dust Mites.
    Bogacz-Piaseczyńska A; Bożek A
    Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allergen-specific immunotherapy for patients with atopic dermatitis sensitized to animal dander.
    Chu H; Park KH; Kim SM; Lee JH; Park JW; Lee KH; Park CO
    Immun Inflamm Dis; 2020 Jun; 8(2):165-169. PubMed ID: 32162849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical improvement and immunological changes in atopic dermatitis patients undergoing subcutaneous immunotherapy with a house dust mite allergoid: a pilot study.
    Bussmann C; Maintz L; Hart J; Allam JP; Vrtala S; Chen KW; Bieber T; Thomas WR; Valenta R; Zuberbier T; Sager A; Novak N
    Clin Exp Allergy; 2007 Sep; 37(9):1277-85. PubMed ID: 17845407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products.
    Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW
    Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CC chemokines as potential immunologic markers correlated with clinical improvement of atopic dermatitis patients by immunotherapy.
    Kwon YS; Oh SH; Wu WH; Bae BG; Lee HJ; Lee MG; Lee KH
    Exp Dermatol; 2010 Mar; 19(3):246-51. PubMed ID: 19758316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Dupilumab-Associated Healing of Alopecia Areata in an Atopic Dermatitis Patient].
    Aszodi N; Pumnea T; Wollenberg A
    Dtsch Med Wochenschr; 2019 May; 144(9):602-605. PubMed ID: 31026869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunoglobulin E and immunoglobulin G4 toward major allergens of house-dust mite during allergen-specific immunotherapy.
    Chen J; Zhou Y; Wang Y; Zheng Y; Lai X; Westermann-Clark E; Cho SH; Kong W
    Am J Rhinol Allergy; 2017 May; 31(3):156-160. PubMed ID: 28490399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen immunotherapy for atopic dermatitis: Systematic review and meta-analysis of benefits and harms.
    Yepes-Nuñez JJ; Guyatt GH; Gómez-Escobar LG; Pérez-Herrera LC; Chu AWL; Ceccaci R; Acosta-Madiedo AS; Wen A; Moreno-López S; MacDonald M; Barrios M; Chu X; Islam N; Gao Y; Wong MM; Couban R; Garcia E; Chapman E; Oykhman P; Chen L; Winders T; Asiniwasis RN; Boguniewicz M; De Benedetto A; Ellison K; Frazier WT; Greenhawt M; Huynh J; Kim E; LeBovidge J; Lind ML; Lio P; Martin SA; O'Brien M; Ong PY; Silverberg JI; Spergel J; Wang J; Wheeler KE; Schneider L; Chu DK
    J Allergy Clin Immunol; 2023 Jan; 151(1):147-158. PubMed ID: 36191689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy.
    Bordas-Le Floch V; Berjont N; Batard T; Varese N; O'Hehir RE; Canonica WG; van Zelm MC; Mascarell L
    Allergy; 2022 Apr; 77(4):1263-1273. PubMed ID: 34551124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sublingual immunotherapy efficacy in patients with atopic dermatitis and house dust mites sensitivity: a prospective pilot study.
    Cadario G; Galluccio AG; Pezza M; Appino A; Milani M; Pecora S; Mastrandrea F
    Curr Med Res Opin; 2007 Oct; 23(10):2503-6. PubMed ID: 17784996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the long-term efficacy and safety of subcutaneous immunotherapy for atopic dermatitis.
    Zhou J; Chen S; Song Z
    Allergy Asthma Proc; 2021 Mar; 42(2):e47-e54. PubMed ID: 33685566
    [No Abstract]   [Full Text] [Related]  

  • 14. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy.
    Batard T; Baron-Bodo V; Martelet A; Le Mignon M; Lemoine P; Jain K; Mariano S; Horiot S; Chabre H; Harwanegg C; Marquette CA; Corgier BP; Soh WT; Satitsuksanoa P; Jacquet A; Chew FT; Nony E; Moingeon P
    Allergy; 2016 Feb; 71(2):220-9. PubMed ID: 26485347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
    Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
    J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety of accelerated schedules of subcutaneous allergen immunotherapy with house dust mite extract in patients with atopic dermatitis.
    Kim ME; Kim JE; Sung JM; Lee JW; Choi GS; Nahm DH
    J Korean Med Sci; 2011 Sep; 26(9):1159-64. PubMed ID: 21935270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular profiling of allergen-antibody IgE might decide about the efficacy of allergen immunotherapy in a patient with atopic dermatitis and allergy to house dust mites.
    Bogacz-Piaseczyńska A; Bożek A; Pastuszczak M; Zalejska-Fiolka J
    Postepy Dermatol Alergol; 2023 Aug; 40(4):542-547. PubMed ID: 37692262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of clinical and immunological parameters after allergen-specific immunotherapy in atopic dermatitis.
    Hajdu K; Kapitány A; Dajnoki Z; Soltész L; Baráth S; Hendrik Z; Veres I; Szegedi A; Gáspár K
    J Eur Acad Dermatol Venereol; 2021 Jun; 35(6):1357-1361. PubMed ID: 33131126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific IgE and IgG4 Profiles of House Dust Mite Components in Allergen-Specific Immunotherapy.
    Yang L; Yang Y; Xu Q; Zhang W; Jiang Q; Li W; Wang Y; Ma D; Lin X; Sun B; Zhu R
    Front Immunol; 2021; 12():786738. PubMed ID: 35197963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing the results of intradermal skin tests for four dust mite allergens in dogs with atopic dermatitis in Thailand.
    Chermprapai S; Anukkul PC; Kritsadasima T; Kromkhun P; Thengchaisri N
    Vet World; 2020 Nov; 13(11):2381-2387. PubMed ID: 33363330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.